Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Panacea Biotec Limited ( (IN:PANACEABIO) ) has shared an announcement.
Panacea Biotec Limited has published its unaudited standalone and consolidated financial results for the quarter ending June 30, 2025, in compliance with SEBI regulations. The financial results were published in Business Standard and Desh Sewak newspapers, indicating the company’s commitment to transparency and regulatory compliance. This announcement may impact the company’s stakeholders by providing insights into its financial health and operational performance.
More about Panacea Biotec Limited
Panacea Biotec Limited operates in the biotechnology and pharmaceutical industry, focusing on the development and manufacturing of vaccines and pharmaceutical formulations. The company is known for its contributions to healthcare through innovative solutions and has a market focus on both domestic and international markets.
Average Trading Volume: 18,236
Technical Sentiment Signal: Buy
Current Market Cap: 25.78B INR
For a thorough assessment of PANACEABIO stock, go to TipRanks’ Stock Analysis page.